2 Venue and contacts 3 Welcome message 5 Committees 17 Awards and grants 24 ISTH information
2 Platelet based coagulation different populations different functions 17 Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome 26 Plasminogen receptors and their role…
223. Coagulation and cancer biological and clinical 234.New developments in the area of factor XIII 245. Laboratory assesment of the anticoagulant effects of the next generation of oral anticoagu…
576. Which test to use to measure the anticoagulant effect of rivaroxaban the prothrombin 579. Which test to use measure the anticoagulant effect of rivaroxaban 581. Weibel palade bodies a window…
663. Structure function relationship in thrombin activatable fibrinolysis inhibitor 645. Platelet immunoreceptor tyrosine based activation motif (ITAM) and hemITAM signaling and vascular integrit…
865 Coagulopathy and its management in patients with severe 875 Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedur…
421. Biosimilars of low molecular weight heparin products fostering competition or reducing biodiversity 427 contact system revisited an interface between inflamation coagulation and innate immun…
231. Shock, acute disseminated intravascular coagulation and microvascular thrombosis is shock liver the unrecognized provocateur of ischemic limb necrosis 236. Structural and functional insights …
3. International society on thrombosis and haemotosis core curiculum project core competencies in clinical thrombosis and hemostasis 28. The contact activation and kalikrein/kinin systems pathophy…
2152. Revisiting the tale of venous thromboembolism in hospitalized medical patients 2155. Central venous catheters and upper extremity deep vein thrombosis (MITH) study 2161. Bemiparin for thro…